Ketamine offers fast relief for treatment-resistant depression but raises safety concerns.
Depression is one of the most common mental health disorders worldwide, and for some, standard treatments just don’t work. Around 10-20% of people with major depressive disorder (MDD) end up with treatment-resistant depression (TRD), meaning they’ve tried at least two different kinds of antidepressants without success. Traditional treatments mostly focus on adjusting brain chemicals like serotonin, but they can take weeks to kick in and don’t always prevent relapse. Because of this, researchers have been looking for faster, more effective alternatives, and one of the most promising options so far is ketamine.
Ketamine was originally developed as an anesthetic, but in recent years, studies have shown that it can quickly relieve symptoms of severe depression, sometimes within hours. It works differently from typical antidepressants by blocking NMDA receptors in the brain, which affects how nerve cells communicate. This appears to help reset brain pathways linked to depression. Ketamine also seems to activate other receptors and chemical systems, influencing mood and possibly reducing inflammation in the brain. The combination of these effects is what makes ketamine such an interesting option for people who haven’t responded to other treatments.
Most often, ketamine is given through an IV infusion, though other methods like nasal sprays and oral tablets are being explored. A common dose is 0.5 mg per kilogram of body weight, and many people experience a noticeable lift in mood within hours. The effects typically last for several days to a week, so repeated treatments are usually needed. Some research suggests that increasing the dose could lead to even better results, but finding the right balance is still an ongoing process. Scientists are still trying to figure out the best dosing schedules to make the benefits last longer without increasing risks.
Like any treatment, ketamine isn’t without its downsides. Some people experience short-term side effects, including feeling disconnected from reality, seeing or hearing things that aren’t there, or temporary spikes in blood pressure and heart rate. These effects tend to wear off quickly, but they can be unsettling. In rare cases, more serious heart-related issues have been reported. There are also concerns about long-term use, as frequent or high-dose ketamine use has been linked to cognitive problems and bladder issues, especially in recreational users. While medical use is controlled and carefully monitored, more research is needed to understand the risks of ongoing ketamine therapy.
Another challenge with ketamine is that its antidepressant effects don’t always last. Some people respond well at first but then find the benefits fade over time. It’s unclear why this happens, and researchers are working to identify ways to make the effects more durable. There’s also a question of whether repeated use could lead to dependence or reduced effectiveness. Additionally, while ketamine has been well studied for major depression, there’s less evidence on how it works for other types of depression, like bipolar depression.
In 2019, a related drug called esketamine was approved by the FDA for treatment-resistant depression. Esketamine is a version of ketamine that’s given as a nasal spray. It’s usually used alongside traditional antidepressants, starting with twice-weekly doses before tapering down to a maintenance schedule. It has shown strong results in relieving depression, much like ketamine, but it still carries concerns about long-term safety and the potential for misuse.
Despite these uncertainties, ketamine has given hope to many who have struggled with depression for years without relief. Its ability to work so quickly makes it especially valuable for those at risk of self-harm or suicide. However, there’s still a lot to learn. Future research will need to focus on finding the best ways to use ketamine safely over the long term, understanding how to predict who will respond best, and figuring out how to extend its benefits. For now, ketamine remains a powerful option for those with treatment-resistant depression, offering a chance at relief when nothing else has worked.
Sources:
Exploring ketamine’s potential in the fight against treatment-resistant depression
The Role of Ketamine in Treatment-resistant Depression: A Narrative Review
Join the conversation!